Evercore ISI upgrades Zimmer Biomet Holdings Inc. [ZBH] to an Outperform rating with a $175 price target
Evercore ISI took its Zimmer Biomet Holdings Inc. [ZBH] rating to the equivalent of an Outperform from an In-line, and the price target to $175, in a research note dated January 04, 2021. That figure represents around a 13.56% premium from where the company’s shares closed on Thursday. Meanwhile, Needham had maintained its rating on […]
